APA (7th ed.) Citation

M, Z., F, N., G, C., ME, O., P, D. L., SI, R., . . . A, T. (2025). Deletion Testing of the DEGS1 Gene Should Be Part of the Diagnostic Pipeline for Hypomyelinating Leukodystrophy (HLD18). Human mutation, 2025, 3531508. https://doi.org/10.1155/humu/3531508

Chicago Style (17th ed.) Citation

M, Zanobio, et al. "Deletion Testing of the DEGS1 Gene Should Be Part of the Diagnostic Pipeline for Hypomyelinating Leukodystrophy (HLD18)." Human Mutation 2025 (2025): 3531508. https://doi.org/10.1155/humu/3531508.

MLA (9th ed.) Citation

M, Zanobio, et al. "Deletion Testing of the DEGS1 Gene Should Be Part of the Diagnostic Pipeline for Hypomyelinating Leukodystrophy (HLD18)." Human Mutation, vol. 2025, 2025, p. 3531508, https://doi.org/10.1155/humu/3531508.